Carregant...
Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas
In aggressive lymphomas, discrepancies in survival reported from experimental and observational studies may reflect selective non-enrolment of high-risk patients in trials. We examined the association between time from diagnosis to chemotherapy and overall survival in diffuse large B-cell (DLBCL), B...
Guardat en:
| Publicat a: | Br J Haematol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980728/ https://ncbi.nlm.nih.gov/pubmed/29687879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15224 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|